Morning Overview on MSN

A Moderna mRNA flu shot won a unanimous FDA panel nod for older adults

Older adults who face the highest rates of flu hospitalization moved one step closer to a new vaccine option on June 18, 2026 ...

Moderna's mRNA flu vaccine backed by FDA advisers

By Christy Santhosh and Mariam Sunny June 18 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its ...

FDA panel recommends mRNA flu vaccine for older adults

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for ...

FDA panel recommends Moderna’s mRNA flu shot for older adults

A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older adults.
Medical Xpress

A higher-dose flu shot could spare millions of older adults a hospital stay

Influenza is a seasonal condition that causes coughing, sneezing, mild fever and aches in most cases. However, it can sometimes take a serious turn, leading to hospitalization, especially for young ...

FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era

The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine is moving a step closer to the U.S. market.

FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama

Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna’s seasonal mRNA ...